Rhiannon Kamstra

456 total citations
25 papers, 375 citations indexed

About

Rhiannon Kamstra is a scholar working on Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health and Family Practice. According to data from OpenAlex, Rhiannon Kamstra has authored 25 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Psychiatry and Mental health and 7 papers in Family Practice. Recurrent topics in Rhiannon Kamstra's work include Diabetes Treatment and Management (8 papers), Schizophrenia research and treatment (8 papers) and Medication Adherence and Compliance (7 papers). Rhiannon Kamstra is often cited by papers focused on Diabetes Treatment and Management (8 papers), Schizophrenia research and treatment (8 papers) and Medication Adherence and Compliance (7 papers). Rhiannon Kamstra collaborates with scholars based in United States and Canada. Rhiannon Kamstra's co-authors include Patrick Lefèbvre, Dominic Pilon, Neeta Tandon, Kruti Joshi, Bruno Émond, Marie‐Hélène Lafeuille, Tony B. Amos, Irina Pivneva, RN and Erik Muser and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and The Journal of Urology.

In The Last Decade

Rhiannon Kamstra

25 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rhiannon Kamstra United States 8 223 105 79 55 55 25 375
Mallik Greene United States 11 455 2.0× 70 0.7× 66 0.8× 39 0.7× 64 1.2× 49 563
Charmi Patel United States 10 255 1.1× 36 0.3× 61 0.8× 40 0.7× 80 1.5× 32 303
Tony B. Amos United States 10 117 0.5× 114 1.1× 75 0.9× 42 0.8× 12 0.2× 24 312
Fuminari Misawa Japan 9 431 1.9× 93 0.9× 24 0.3× 16 0.3× 90 1.6× 28 488
Ralph Aquila United States 10 357 1.6× 77 0.7× 41 0.5× 41 0.7× 77 1.4× 15 446
Maila Majak Sweden 6 581 2.6× 77 0.7× 91 1.2× 42 0.8× 172 3.1× 8 734
Leon Dupclay United States 11 199 0.9× 28 0.3× 32 0.4× 45 0.8× 28 0.5× 12 638
Corina Young United Kingdom 9 530 2.4× 84 0.8× 41 0.5× 36 0.7× 154 2.8× 11 630
F. Cañas Spain 9 323 1.4× 50 0.5× 50 0.6× 38 0.7× 57 1.0× 25 453
L. Hargarter Germany 12 453 2.0× 52 0.5× 33 0.4× 25 0.5× 147 2.7× 33 497

Countries citing papers authored by Rhiannon Kamstra

Since Specialization
Citations

This map shows the geographic impact of Rhiannon Kamstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhiannon Kamstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhiannon Kamstra more than expected).

Fields of papers citing papers by Rhiannon Kamstra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhiannon Kamstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhiannon Kamstra. The network helps show where Rhiannon Kamstra may publish in the future.

Co-authorship network of co-authors of Rhiannon Kamstra

This figure shows the co-authorship network connecting the top 25 collaborators of Rhiannon Kamstra. A scholar is included among the top collaborators of Rhiannon Kamstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhiannon Kamstra. Rhiannon Kamstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamstra, Rhiannon, et al.. (2024). School Vaccine Coverage and Medical Exemption Uptake After the New York State Repeal of Nonmedical Vaccination Exemptions. JAMA Network Open. 7(2). e2354710–e2354710. 3 indexed citations
2.
3.
4.
Kamstra, Rhiannon, Dominic Pilon, Patrick Lefèbvre, Bruno Émond, & Kruti Joshi. (2018). Treatment Patterns and Medicaid Spending in Comorbid Schizophrenia Populations: Once-Monthly Paliperidone Palmitate Vs Oral Atypical Antipsychotics. Value in Health. 21. S180–S180. 1 indexed citations
5.
Wysham, Carol, Dominic Pilon, Marie‐Hélène Lafeuille, et al.. (2018). Quality goal attainment and maintenance in patients with type II diabetes mellitus initiated on canagliflozin or a glucagon-like peptide-1 receptor agonist in an actual practice setting. Current Medical Research and Opinion. 34(6). 1125–1133. 8 indexed citations
6.
Wysham, Carol, Patrick Lefèbvre, Dominic Pilon, et al.. (2018). An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical records. Journal of Diabetes and its Complications. 33(2). 140–147. 6 indexed citations
7.
Amos, Tony B., Neeta Tandon, Patrick Lefèbvre, et al.. (2018). Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression. The Journal of Clinical Psychiatry. 79(2). 24–32. 105 indexed citations
8.
Kamstra, Rhiannon, Jennifer Cai, Brahim Bookhart, et al.. (2018). Economic modelling of costs associated with outcomes reported for type 2 diabetes mellitus (T2DM) patients in the CANVAS and EMPA-REG cardiovascular outcomes trials. Journal of Medical Economics. 22(3). 280–287. 7 indexed citations
9.
Lafeuille, Marie‐Hélène, Neeta Tandon, Rhiannon Kamstra, et al.. (2018). Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics. Drugs - Real World Outcomes. 5(1). 81–90. 10 indexed citations
10.
Freedland, Stephen J., Yinong Young‐Xu, Dominic Pilon, et al.. (2018). MP52-11 ASSOCIATION OF DOSE REDUCTION OF ABIRATERONE ACETATE PLUS PREDNISONE OR ENZALUTAMIDE AND PSA PROGRESSION IN VETERANS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER. The Journal of Urology. 199(4S). 1 indexed citations
11.
Young‐Xu, Yinong, Dominic Pilon, Rachel H. Bhak, et al.. (2018). Predictors of overall survival (OS) in veterans with non-metastatic castration resistant prostate cancer (nmCRPC).. Journal of Clinical Oncology. 36(15_suppl). e17057–e17057. 2 indexed citations
12.
Wysham, Carol, Patrick Lefèbvre, Dominic Pilon, et al.. (2017). Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors. BMC Endocrine Disorders. 17(1). 32–32. 4 indexed citations
13.
Pilon, Dominic, Kruti Joshi, Neeta Tandon, et al.. (2017). Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic. Patient Preference and Adherence. Volume 11. 619–629. 41 indexed citations
14.
Pilon, Dominic, Neeta Tandon, Marie‐Hélène Lafeuille, et al.. (2017). Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics. Clinical Therapeutics. 39(10). 1972–1985.e2. 78 indexed citations
15.
16.
Lefèbvre, Patrick, Dominic Pilon, Marie‐Hélène Lafeuille, et al.. (2017). Abstract #290: Real-World Persistence and HBA1C Goal Attainment in Patients with Type Ii Diabetes Mellitus Initiated on Canagliflozin or a Glucagon-Like Peptide-1 Receptor Agonist. Endocrine Practice. 23. 80–80. 1 indexed citations
17.
Kamstra, Rhiannon, Laurent Azoulay, Russell Steele, Marina B. Klein, & Christina Greenaway. (2016). Hospitalizations in Immigrants and Nonimmigrants Diagnosed With Chronic Hepatitis C Infection in Québec. Clinical Infectious Diseases. 63(11). 1439–1448. 7 indexed citations
18.
Kamstra, Rhiannon, Andrew Freywald, & Wely B. Floriano. (2015). N‐(2,4)‐dinitrophenyl‐L‐arginine Interacts with EphB4 and Functions as an EphB4 Kinase Modulator. Chemical Biology & Drug Design. 86(4). 476–486. 4 indexed citations
19.
Kamstra, Rhiannon & Wely B. Floriano. (2014). Identifying potential selective fluorescent probes for cancer-associated protein carbonic anhydrase IX using a computational approach. Journal of Molecular Graphics and Modelling. 54. 184–193. 2 indexed citations
20.
Kamstra, Rhiannon, et al.. (2014). Creating and virtually screening databases of fluorescently-labelled compounds for the discovery of target-specific molecular probes. Journal of Computer-Aided Molecular Design. 28(11). 1129–1142. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mallik Greene Breakdown of academic impact, for papers by Charmi Patel Breakdown of academic impact, for papers by Tony B. Amos Breakdown of academic impact, for papers by Fuminari Misawa Breakdown of academic impact, for papers by Ralph Aquila Breakdown of academic impact, for papers by Maila Majak Breakdown of academic impact, for papers by Leon Dupclay Breakdown of academic impact, for papers by Corina Young Breakdown of academic impact, for papers by F. Cañas Breakdown of academic impact, for papers by L. Hargarter
Rankless by CCL
2026